Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Up 1.83%

Collegium Pharmaceutical reported a loss per share of $0.39, which was below expectations, although there was a positive stock reaction with a 1.83% increase. The lack of revenue data and management commentary leaves uncertainty about the company's performance and future direction. Investors may be reacting to other factors or market sentiment rather than the earnings results alone.